LipidDoc_ATL said:It helps to say which part of this you are uncertain about.
True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.
LipidDoc_ATL said:It helps to say which part of this you are uncertain about.
True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.
Dr.PainCLE said:Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 334 dB/m (moderate steatosis) and stiffness 9.8 kPa (possible…
Thank you for spelling out the reasoning rather than just the conclusion. Printing the relevant bit and taking it with me.
LipidDoc_ATL said:It helps to say which part of this you are uncertain about.
This is where I part company with the consensus forming above. Pushing back on the anecdote-stacking. Twenty people reporting the same thing is twenty samples from the same self-selected pool, not twenty independent confirmations.
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsThe figures, for anyone assembling their own picture. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.
Moderator note: two posts asking for a source have been merged into one. Please search the thread before asking again. Tagging this one for the weekly digest.